ES2596722B1 - MAGISTRAL FORMULA AND OBTAINING PROCEDURE - Google Patents
MAGISTRAL FORMULA AND OBTAINING PROCEDURE Download PDFInfo
- Publication number
- ES2596722B1 ES2596722B1 ES201531004A ES201531004A ES2596722B1 ES 2596722 B1 ES2596722 B1 ES 2596722B1 ES 201531004 A ES201531004 A ES 201531004A ES 201531004 A ES201531004 A ES 201531004A ES 2596722 B1 ES2596722 B1 ES 2596722B1
- Authority
- ES
- Spain
- Prior art keywords
- grams
- flowering
- sum
- officinalis
- master formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- 241000965806 Umbilicaria pustulata Species 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 10
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 10
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 10
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 10
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 10
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims abstract description 10
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 9
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 9
- 235000010701 Lavanda vera Nutrition 0.000 claims abstract description 9
- 241000241413 Propolis Species 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 9
- 229940069949 propolis Drugs 0.000 claims abstract description 9
- 229940098465 tincture Drugs 0.000 claims abstract description 9
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 8
- 235000008697 Cannabis sativa Nutrition 0.000 claims abstract description 8
- 235000013871 bee wax Nutrition 0.000 claims abstract description 8
- 239000012166 beeswax Substances 0.000 claims abstract description 8
- 239000004166 Lanolin Substances 0.000 claims abstract description 7
- 235000019388 lanolin Nutrition 0.000 claims abstract description 7
- 229940039717 lanolin Drugs 0.000 claims abstract description 7
- 239000004006 olive oil Substances 0.000 claims abstract description 3
- 235000008390 olive oil Nutrition 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims description 9
- 230000002745 absorbent Effects 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims description 4
- 239000003981 vehicle Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 239000004264 Petrolatum Substances 0.000 abstract description 3
- 229940066842 petrolatum Drugs 0.000 abstract description 3
- 229940092738 beeswax Drugs 0.000 abstract description 2
- 239000001993 wax Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Fórmula magistral y procedimiento de obtención, con base de vaselina, lanolina, cera de abeja, aceite de oliva o sus mezclas, comprende Lasallia pustulata y sumidad florida de Thymus vulgaris, Lavandula officinalis, miel, y tintura de propóleo, opcionalmente hojas de Cannabis sativa y sumidad florida de Calendula officinalis. Por cada 1 kg de base, contiene: - 50 gramos de Lasallia pustulata. 50 gramos de Thymus vulgaris. 50 gramos de Lavandula officinalis. 250 gramos de cera de abeja. 40 gramos de miel pura de abeja. - 6,5 gramos de tintura de propóleo. Opcionalmente, hasta 150 gramos de Lasallia pustulata, hojas de Cannabis sativa, y Calendula officinalis.#Para su obtención, se calienta la base, se introduce sumidad florida de Thymus vulgaris, Lavandula officinalis, Calendula officinalis, Lasallia pustulata, hojas de Cannabis sativa, seco y pulverizado. Se mantiene a 65°-80° cinco horas, se introduce la cera, la miel, la tintura de propóleo y se filtra.Master formula and method of production, based on petrolatum, lanolin, beeswax, olive oil or mixtures thereof, includes Lasallia pustulata and florida sum of Thymus vulgaris, Lavandula officinalis, honey, and propolis tincture, optionally Cannabis sativa leaves and florida sumidad of Calendula officinalis. For every 1 kg of base, it contains: - 50 grams of Lasallia pustulata. - 50 grams of Thymus vulgaris. - 50 grams of Lavandula officinalis. - 250 grams of beeswax. —40 grams of pure honey. - 6.5 grams of propolis tincture. Optionally, up to 150 grams of Lasallia pustulata, Cannabis sativa leaves, and Calendula officinalis. # To obtain it, the base is heated, a flowering sum of Thymus vulgaris, Lavandula officinalis, Calendula officinalis, Lasallia pustulata, Cannabis sativa leaves, is introduced dry and powdered It is kept at 65 ° -80 ° five hours, the wax, honey, propolis tincture is introduced and filtered.
Description
55
1010
15fifteen
20twenty
2525
3030
3535
FORMULA MAGISTRAL Y PROCEDIMIENTO DE OBTENCIONMAGISTRAL FORMULA AND PROCEDURE OF OBTAINING
D E S C R I P C I OND E S C R I P C I ON
OBJETO DE LA INVENCIONOBJECT OF THE INVENTION
La invention, tal como expresa el enunciado de la presente memoria descriptiva, se refiere a una formula magistral y al procedimiento de obtencion de la misma.The invention, as expressed in the statement of the present specification, refers to a master formula and the method for obtaining it.
Mas en particular, el objeto de la invencion se centra en una composition de aplicacion topica que, comprendiendo al menos un vehteulo absorbente, como la vaselina u otro, y, entre otros ingredientes, incorpora un liquen de efecto antibiotico y cicatrizante, en concreto Lasallia pustulata, sirviendo, entre otras aplicaciones, como crema analgesica antiinflamatoria y cicatrizante.More particularly, the object of the invention focuses on a topical application composition which, comprising at least one absorbent vehicle, such as petroleum jelly or other, and, among other ingredients, incorporates a lichen of antibiotic and healing effect, in particular Lasallia Pustulata, serving, among other applications, as an anti-inflammatory and healing analgesic cream.
ANTECEDENTES DE LA INVENCIONBACKGROUND OF THE INVENTION
Como referencia al estado actual de la tecnica, cabe senalar que, al menos por parte del solicitante, se desconoce la existencia formulas de aplicacion topica que combinen los principios activos o elementos que comprende la que aqu se preconiza, segun se reivindica.As a reference to the current state of the art, it should be noted that, at least on the part of the applicant, the existence of topical application formulas that combine the active principles or elements comprising what is recommended herein is unknown, as claimed.
EXPLICACION DE LA INVENCIONEXPLANATION OF THE INVENTION
La formula magistral que la invencion propone es un producto de aplicacion topica con efecto analgesico antiinflamatorio y cicatrizante, sirviendo, preferentemente, para herpes labiales, cicatrization de heridas, dolores musculares, golpes, picaduras de insectos, fistulas anales, y afecciones dermatologicas como psoriasis o eccemas, entre otros procesos patologicos.The master formula proposed by the invention is a topical application product with an anti-inflammatory and healing analgesic effect, preferably serving for cold sores, wound healing, muscle aches, bumps, insect bites, anal fistulas, and dermatological conditions such as psoriasis or eczema, among other pathological processes.
Mas concretamente, la formula magistral que la invencion propone, ademas de un elemento base como vehiculo absorbente, que, preferentemente es vaselina, lanolina, cera de abeja, o aceite de oliva o una mezcla de ellos, se distingue por el hecho de comprender Lasallia pustulata, liquen que tiene propiedades cicatrizantes y antibioticas.More specifically, the master formula that the invention proposes, in addition to a base element as an absorbent vehicle, which is preferably petrolatum, lanolin, beeswax, or olive oil or a mixture thereof, is distinguished by the fact of understanding Lasallia Pustulata, lichen that has healing and antibiotic properties.
Preferentemente, ademas, la formula incorpora tambien los siguientes ingredientes, enPreferably, in addition, the formula also incorporates the following ingredients, in
55
1010
15fifteen
20twenty
2525
3030
3535
conjunto o en cualquier posible mezcla de los mismos:set or in any possible mixture thereof:
- Sumidad florida de Thymus vulgaris (tomillo), que tiene actividad antiinflamatoria y antiseptica.- Thymus vulgaris florida (thyme), which has anti-inflammatory and antiseptic activity.
- Sumidad florida Lavandula officinalis (lavanda), que tiene actividad antiinflamatoria, antivmca y calmante del dolor.- Sumidad florida Lavandula officinalis (lavender), which has anti-inflammatory, antivmca and pain relieving activity.
- Miel pura de abeja, coadyuvante en la cicatrizacion de heridas.- Pure honey, an aid in wound healing.
- Tintura de propoleo, que tambien tiene accion antibiotica.- Propolis tincture, which also has antibiotic action.
Sin embargo, en la realization preferida de la invention, la formula magistral contiene, por cada 1 kg de vaselina, o lanolina, o base absorbente similar:However, in the preferred embodiment of the invention, the master formula contains, for every 1 kg of petrolatum, or lanolin, or similar absorbent base:
- entre 100 gramos y 50 gramos de Lasallia pustulata.- between 100 grams and 50 grams of Lasallia pustulata.
- 50 gramos de sumidad florida de Thymus vulgaris.- 50 grams of flowery Thymus vulgaris.
- 50 gramos de sumidad florida de Lavandula officinalis.- 50 grams of flowering tops of Lavandula officinalis.
- 250 gramos de cera de abeja.- 250 grams of beeswax.
- 40 gramos de miel pura de abeja.- 40 grams of pure honey.
- 6,5 gramos (100 gotas) de tintura de propoleo.- 6.5 grams (100 drops) of propolis tincture.
En una variante opcional de la formula con funcion cicatrizante y/o reparadora de la piel y antibiotica, por cada 10 gramos de vaselina o base absorbente similar de la composition antedicha se anaden hasta 1,5 gramos de Lasallia pustulata, es decir, 150 gramos en el ejemplo de 1 kg descrito, lo cual aumenta la actividad cicatrizante de heridas y antibiotica.In an optional variant of the formula with healing and / or reparative function of the skin and antibiotic, for every 10 grams of petroleum jelly or similar absorbent base of the above composition, up to 1.5 grams of Lasallia pustulata are added, that is, 150 grams in the example of 1 kg described, which increases the healing activity of wounds and antibiotics.
Asimismo, la formula tambien contempla otra variante de realizacion opcional en la que, ademas se incorpora hojas de Cannabis sativa (hojas de marihuana) y sumidad florida de Calendula officinalis (calendula) entre sus ingredientes, preferentemente, en una cantidad de 50 gramos de cada uno, para las proporciones de la composicion descrita como preferida.Likewise, the formula also contemplates another variant of optional embodiment in which, in addition, Cannabis sativa leaves (marijuana leaves) and florid sum of Calendula officinalis (calendula) are incorporated among its ingredients, preferably, in an amount of 50 grams of each one, for the proportions of the composition described as preferred.
En cuanto al procedimiento de preparation de la formula descrita, contempla los siguientes pasos:As for the preparation procedure of the described formula, it contemplates the following steps:
- Se calienta en un bano Maria la base absorbente, consistente en vaselina, lanolina, o mezcla, hasta su disolucion.- The absorbent base, consisting of petroleum jelly, lanolin, or mixture, is heated in a bath, until dissolved.
- Una vez liquida, se introduce la sumidad florida de Thymus vulgaris, Lavandula officinalis y,- Once liquid, the flowering sum of Thymus vulgaris, Lavandula officinalis and,
55
1010
15fifteen
20twenty
2525
3030
3535
en su caso, de la Calendula officinalis. Todo ello previamente seco y pulverizado.where appropriate, of Calendula officinalis. All previously dried and powdered.
- Luego se incorpora la Lasallia pustulata y, en su caso, las hojas de Cannabis sativa. Tambien previamente seco y pulverizado.- Then Lasallia pustulata and, where appropriate, the leaves of Cannabis sativa are incorporated. Also previously dry and pulverized.
- Se mantienen a una temperatura entre 65° y 80° y se deja que se mezclen los ingredientes durante cinco horas.- They are kept at a temperature between 65 ° and 80 ° and the ingredients are allowed to mix for five hours.
- Cuando han pasado cuatro horas, se introduce la cera de abeja y la miel.- When four hours have passed, beeswax and honey are introduced.
- Durante los ultimos quince minutos, se introduce la tintura de propoleo.- During the last fifteen minutes, the tincture of propolis is introduced.
- Por ultimo se filtra la mezcla obtenida.- Finally, the mixture obtained is filtered.
Descrita suficientemente la naturaleza de la presente invencion, asi como la manera de ponerla en practica, no se considera necesario hacer mas extensa su explication, haciendose constar que, dentro de su esencialidad, podra ser llevada a la practica en otras formas de realization que difieran en detalle de la indicada a trtulo de ejemplo, y a las cuales alcanzara igualmente la protection que se recaba siempre que no se altere, cambie o modifique su principio fundamental.Described sufficiently the nature of the present invention, as well as the way of putting it into practice, it is not considered necessary to make its explanation more extensive, stating that, within its essentiality, it can be put into practice in other forms of realization that differ in detail of the one indicated by way of example, and to which it will also reach the protection that is sought as long as it is not altered, changed or modified its fundamental principle.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531004A ES2596722B1 (en) | 2015-07-10 | 2015-07-10 | MAGISTRAL FORMULA AND OBTAINING PROCEDURE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531004A ES2596722B1 (en) | 2015-07-10 | 2015-07-10 | MAGISTRAL FORMULA AND OBTAINING PROCEDURE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2596722A1 ES2596722A1 (en) | 2017-01-11 |
| ES2596722B1 true ES2596722B1 (en) | 2017-09-18 |
Family
ID=57709317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201531004A Active ES2596722B1 (en) | 2015-07-10 | 2015-07-10 | MAGISTRAL FORMULA AND OBTAINING PROCEDURE |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2596722B1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL126987A (en) * | 1996-05-10 | 2001-09-13 | Nino Shikhashvili | Green ointment for burn and wound treatment |
| AT406731B (en) * | 1998-04-24 | 2000-08-25 | Dado Suleiman | SUBSTANCE MIXTURE FOR TOPICAL APPLICATION |
| WO2005120452A1 (en) * | 2004-06-07 | 2005-12-22 | Katica Pavlovic | A procedure in production of a curative creams for regeneration of skin tissue, easer breathing, psoriasis, pains and tiredness in legs |
-
2015
- 2015-07-10 ES ES201531004A patent/ES2596722B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2596722A1 (en) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6060084B2 (en) | Composition for the treatment of peripheral ulcers of various causes | |
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| Mensah et al. | Anti-inflammatory and antioxidant activities of Commelina diffusa (Commelinaceae) | |
| ES2596722B1 (en) | MAGISTRAL FORMULA AND OBTAINING PROCEDURE | |
| RU2325175C2 (en) | Ointment for burns, dermatoses treatment and wound healing | |
| WO2020251478A1 (en) | Natural wound oinment | |
| Nguyen Le et al. | Formulation and Evaluation of Herbal Emulsion-Based Gel Containing Combined Essential Oils from Melaleuca alternifolia and Citrus hystrix. | |
| RU2328301C2 (en) | Antibacterial, antiinflammatory ointment | |
| RU2287995C1 (en) | Wound-healing preparation (variants) | |
| ES2593261B1 (en) | PRODUCT IN CREAM OF TOPICAL USE FOR THE TREATMENT OF SKIN DISEASES AND PROCEDURE OF OBTAINING | |
| EP2644202B1 (en) | Ointment for skin treatment, and method of its manufacture | |
| RO126996B1 (en) | Cream for the treatment of anal fissures and process for preparing the same | |
| Damavandi | Quadruple or triple action creams for insect venom treatments | |
| Tagiyeva et al. | Pharmaceutical sciences | |
| WO2010022485A1 (en) | Pharmaceutical composition comprising an extract of calendula subspecies | |
| Yuryeva et al. | Arnica as a promising raw material for the creation of homeopathic dosage forms | |
| ES2211321B1 (en) | PUMP FOR THE TREATMENT OF HEMORROIDS, RAW MATERIAL FOR OBTAINING AND PROCEDURE FOR PREPARATION OF SUCH PUMP. | |
| RU2015126018A (en) | APPLICATION OF THE SALT AND SUGAR MIXTURE FOR THE PRODUCTION OF THE MEDICINE USED FOR THE TREATMENT OF VASCULAR MUSCLES OR MULTI-FEMALING TENSION SYNDROME | |
| RO123291B1 (en) | Ointment for treating rheumatism | |
| ES1299174U (en) | COSMETIC CREAM FOR TOPICAL APPLICATION ON THE SKIN (Machine-translation by Google Translate, not legally binding) | |
| IT202200025185A1 (en) | Preparation of a composition of substances "LOTION" containing Fermented RICE WATER, TAE-TREE essential oil, LAVENDER essential oil, ROSEMARY essential oil, JOJOBA oil and WATER, for effective treatment to restore, improve and maintain the skin and the dermis layer of the skull | |
| CN115154567A (en) | Preservative-free multi-purpose traditional Chinese medicine formula for promoting blood circulation and removing blood stasis | |
| JP2004300063A (en) | Skin care preparation for external use | |
| CN111956687A (en) | Bacteriostatic foot care solution containing plant essential oil and preparation method of foot care solution | |
| RU2022104737A (en) | COMPOSITIONS FOR TREATMENT OF ATOPIC DERMATITIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2596722 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170918 |